Switzerland
Swiss economy records strongest quarterly growth in nearly five years
Switzerland’s economy grew 1.5% in the second quarter, its strongest quarterly expansion since late 2021. The rebound was driven by chemicals and pharmaceuticals, a sharp recovery in exports and stronger investment, although household consumption remained subdued.

Swiss GDP Rebounds at Fastest Pace Since 2021
Swiss GDP grew 1.5% in the second quarter of 2026, delivering the country’s strongest quarterly expansion since late 2021. The State Secretariat for Economic Affairs, known as SECO, confirmed the figure in its second estimate on Thursday, September 3, after publishing an initial estimate in mid August.
The result marks a clear acceleration from the first quarter, when the economy expanded by 0.55%, adjusted for sporting events. SECO said the latest performance represented the strongest GDP growth since the third quarter of 2021.
The rebound came from the export heavy parts of the Swiss economy. Chemicals and pharmaceuticals led the advance, while manufacturing, financial services and transport also recorded growth. Exports excluding transit trade rose sharply, and companies increased investment in capital goods after cutting it at the start of the year.
The figures give Bern, businesses and investors evidence of a forceful recovery in the middle of 2026. They also show how dependent the quarterly result was on industrial and external demand. Household spending, a major support for the domestic economy, remained weak. The second quarter therefore produced a powerful national figure without a broad surge in consumer activity.
Pharmaceuticals Power the Industrial Engine
The chemicals and pharmaceuticals sector expanded 10.5%, making it the central force behind the quarterly rebound. SECO identified the industry as the strongest source of momentum, even as companies faced uncertainty around potential United States tariffs.
The sector’s performance reflects the weight of life sciences and advanced manufacturing in the Swiss economy. Basel and the surrounding northwestern Swiss region host major pharmaceutical and chemical operations, while research, precision production and global supply networks connect the industry to markets far beyond Switzerland.
Manufacturing as a whole grew 4.5%, adding breadth to the industrial recovery. Financial services and transport each increased by 1.9%, indicating that the quarter’s gains extended beyond laboratories and factories. Services grew more moderately, by 0.7%.
SECO said value added rose in many other sectors, although the data release did not provide a canton by canton breakdown. The figures point to an economy benefiting from internationally oriented industries, with pharmaceuticals providing the largest contribution. Tariff uncertainty remains a factor for companies planning production and exports, but it did not prevent the sector from posting its strongest reported contribution to the quarter.
Exports and Investment Turn the Corner
Exports excluding transit trade jumped 9.7% in the second quarter, reversing a 1.2% decline between January and March. The turnaround supplied a major lift to an economy whose manufacturers and pharmaceutical companies sell heavily abroad.
The export recovery arrived alongside renewed business investment. Investment in capital goods rose 0.8%, following a 1.2% fall in the first quarter. The change suggests companies resumed spending on equipment and productive capacity after a weaker opening to the year. SECO did not identify the individual products or destinations behind the export increase in the figures cited.
Transport grew 1.9%, a result consistent with stronger movement of goods and services, although the official release does not establish a direct causal link. Financial services also expanded by 1.9%, while wider services recorded more restrained growth of 0.7%.
For Swiss companies, the second quarter delivered relief through external demand and investment. For policymakers, it also underlined the exposure that comes with an export led model. The figures cover a single quarter and do not resolve the tariff uncertainty facing internationally active firms, particularly in chemicals and pharmaceuticals.
Households Lag Behind the Recovery
Private consumption rose only 0.3%, after increasing 0.1% in the first quarter. The subdued household figure places a limit on how broadly the recovery has spread through Swiss domestic life, even as the headline GDP number accelerates.
Household consumption is one of the driving forces behind Switzerland’s economy. Its modest increase indicates that consumers did not match the pace set by exporters, manufacturers and pharmaceutical producers during the quarter. The source does not provide a breakdown by spending category, household type or canton, so the national figure cannot show which parts of the country experienced the strongest consumer response.
That distinction matters for the months ahead. A recovery led by foreign demand can lift production and investment quickly, while household spending may respond more gradually. Companies connected to international markets benefited most visibly in the second quarter. Domestic businesses tied to everyday consumer demand saw a smaller immediate boost in the available data.
SECO’s release confirms a strong quarter, not a complete picture of economic momentum. The next estimates will show whether exports, industrial output and investment continue to support growth, and whether consumers begin to contribute more decisively.